Study on highly sensitive sensing method for biomarkers based on functional nanomaterials

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058628

Enrollment

Unknown

Registered

2022-04-12

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Gold Standard:The results were consistent with commercial ELISA or PCR kits

Index test:Concentration of representative disease markers (such as cytokine VEGF or small molecule markers)

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Null

Exclusion criteria

Exclusion criteria: Null

Design outcomes

Primary

Measure	Time frame
VEGF concentration;sIL-6R concentration;Bilirubin concentration;	—

Countries

China

Contacts

Public ContactJikai Wang

University of South China

jkwang@hnu.edu.cn15273320396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026